142 related articles for article (PubMed ID: 29505790)
1. Berberine alleviates hepatic lipid accumulation by increasing ABCA1 through the protein kinase C δ pathway.
Liang H; Wang Y
Biochem Biophys Res Commun; 2018 Apr; 498(3):473-480. PubMed ID: 29505790
[TBL] [Abstract][Full Text] [Related]
2. ApoA-I or ABCA1 expression suppresses fatty acid synthesis by reducing 27-hydroxycholesterol levels.
Ma D; Liu W; Wang Y
Biochimie; 2014 Aug; 103():101-8. PubMed ID: 24793484
[TBL] [Abstract][Full Text] [Related]
3. Apolipoprotein A-I and adenosine triphosphate-binding cassette transporter A1 expression alleviates lipid accumulation in hepatocytes.
Liu W; Qin L; Yu H; Lv F; Wang Y
J Gastroenterol Hepatol; 2014 Mar; 29(3):614-22. PubMed ID: 24219083
[TBL] [Abstract][Full Text] [Related]
4. Apolipoprotein A-I expression suppresses COX-2 expression by reducing reactive oxygen species in hepatocytes.
Mao J; Liu W; Wang Y
Biochem Biophys Res Commun; 2014 Nov; 454(3):359-63. PubMed ID: 25451254
[TBL] [Abstract][Full Text] [Related]
5. Role of ATP-binding cassette transporter A1 in suppressing lipid accumulation by glucagon-like peptide-1 agonist in hepatocytes.
Lyu J; Imachi H; Fukunaga K; Sato S; Kobayashi T; Dong T; Saheki T; Matsumoto M; Iwama H; Zhang H; Murao K
Mol Metab; 2020 Apr; 34():16-26. PubMed ID: 32180556
[TBL] [Abstract][Full Text] [Related]
6. Berberine prevents progression from hepatic steatosis to steatohepatitis and fibrosis by reducing endoplasmic reticulum stress.
Zhang Z; Li B; Meng X; Yao S; Jin L; Yang J; Wang J; Zhang H; Zhang Z; Cai D; Zhang Y; Ning G
Sci Rep; 2016 Feb; 6():20848. PubMed ID: 26857750
[TBL] [Abstract][Full Text] [Related]
7. Unsaturated fatty acids phosphorylate and destabilize ABCA1 through a protein kinase C delta pathway.
Wang Y; Oram JF
J Lipid Res; 2007 May; 48(5):1062-8. PubMed ID: 17325386
[TBL] [Abstract][Full Text] [Related]
8. Overexpression of apolipoprotein A-I alleviates endoplasmic reticulum stress in hepatocytes.
Guo Q; Zhang C; Wang Y
Lipids Health Dis; 2017 Jun; 16(1):105. PubMed ID: 28577569
[TBL] [Abstract][Full Text] [Related]
9. ERK-dependent mTOR pathway is involved in berberine-induced autophagy in hepatic steatosis.
He Q; Mei D; Sha S; Fan S; Wang L; Dong M
J Mol Endocrinol; 2016 Nov; 57(4):251-260. PubMed ID: 27658958
[TBL] [Abstract][Full Text] [Related]
10. Berberine Ameliorates Hepatic Steatosis and Suppresses Liver and Adipose Tissue Inflammation in Mice with Diet-induced Obesity.
Guo T; Woo SL; Guo X; Li H; Zheng J; Botchlett R; Liu M; Pei Y; Xu H; Cai Y; Zeng T; Chen L; Li X; Li Q; Xiao X; Huo Y; Wu C
Sci Rep; 2016 Mar; 6():22612. PubMed ID: 26936230
[TBL] [Abstract][Full Text] [Related]
11. Suppression of ABCA1 by unsaturated fatty acids leads to lipid accumulation in HepG2 cells.
Yang Y; Jiang Y; Wang Y; An W
Biochimie; 2010 Aug; 92(8):958-63. PubMed ID: 20385201
[TBL] [Abstract][Full Text] [Related]
12. Berberine alleviates nonalcoholic fatty liver induced by a high-fat diet in mice by activating SIRT3.
Xu X; Zhu XP; Bai JY; Xia P; Li Y; Lu Y; Li XY; Gao X
FASEB J; 2019 Jun; 33(6):7289-7300. PubMed ID: 30848932
[TBL] [Abstract][Full Text] [Related]
13. Orally Administered Berberine Modulates Hepatic Lipid Metabolism by Altering Microbial Bile Acid Metabolism and the Intestinal FXR Signaling Pathway.
Sun R; Yang N; Kong B; Cao B; Feng D; Yu X; Ge C; Huang J; Shen J; Wang P; Feng S; Fei F; Guo J; He J; Aa N; Chen Q; Pan Y; Schumacher JD; Yang CS; Guo GL; Aa J; Wang G
Mol Pharmacol; 2017 Feb; 91(2):110-122. PubMed ID: 27932556
[TBL] [Abstract][Full Text] [Related]
14. Berberine improves glucogenesis and lipid metabolism in nonalcoholic fatty liver disease.
Zhao L; Cang Z; Sun H; Nie X; Wang N; Lu Y
BMC Endocr Disord; 2017 Feb; 17(1):13. PubMed ID: 28241817
[TBL] [Abstract][Full Text] [Related]
15. Berberine Ameliorates High-Fat Diet-Induced Non-Alcoholic Fatty Liver Disease in Rats via Activation of SIRT3/AMPK/ACC Pathway.
Zhang YP; Deng YJ; Tang KR; Chen RS; Liang S; Liang YJ; Han L; Jin L; Liang ZE; Chen YN; Yang QH
Curr Med Sci; 2019 Feb; 39(1):37-43. PubMed ID: 30868489
[TBL] [Abstract][Full Text] [Related]
16. Berberine directly targets AKR1B10 protein to modulate lipid and glucose metabolism disorders in NAFLD.
Yang S; Cao SJ; Li CY; Zhang Q; Zhang BL; Qiu F; Kang N
J Ethnopharmacol; 2024 Oct; 332():118354. PubMed ID: 38762210
[TBL] [Abstract][Full Text] [Related]
17. Berberine Ameliorates Abnormal Lipid Metabolism via the Adenosine Monophosphate-Activated Protein Kinase/Sirtuin 1 Pathway in Alcohol-Related Liver Disease.
Zhu L; Xu JJ; Li HD; Li JJ; Cheng M; Niu XN; Jia PC; Liu JY; Huang C; Lv XW; Li J
Lab Invest; 2023 Apr; 103(4):100041. PubMed ID: 36870291
[TBL] [Abstract][Full Text] [Related]
18. Berberine alleviates lipid metabolism disorders via inhibition of mitochondrial complex I in gut and liver.
Yu M; Alimujiang M; Hu L; Liu F; Bao Y; Yin J
Int J Biol Sci; 2021; 17(7):1693-1707. PubMed ID: 33994854
[TBL] [Abstract][Full Text] [Related]
19. Berberine Prevents Disease Progression of Nonalcoholic Steatohepatitis through Modulating Multiple Pathways.
Wang Y; Tai YL; Zhao D; Zhang Y; Yan J; Kakiyama G; Wang X; Gurley EC; Liu J; Liu J; Liu J; Lai G; Hylemon PB; Pandak WM; Chen W; Zhou H
Cells; 2021 Jan; 10(2):. PubMed ID: 33494295
[TBL] [Abstract][Full Text] [Related]
20. Unsaturated fatty acids repress the expression of ATP-binding cassette transporter A1 in HepG2 and FHs 74 Int cells.
Ku CS; Rasmussen HE; Park Y; Jesch ED; Lee J
Nutr Res; 2011 Apr; 31(4):278-85. PubMed ID: 21530801
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
